Open Therapeutics is Awarded a Grant from the Blockchain-based Polygon Decentralized Autonomous Organization (PolygonDAO)
Through this award, Open Therapeutics will accelerate its Web3.0 Polygon blockchain implementation.
Cincinnati, OH, and Polygon DAO — November 8, 2022 — Open Therapeutics an open science company was awarded a grant from the leading blockchain developer organization, the Polygon Decentralized Autonomous Organization (Polygon DAO).
The PolygonDAO is a global blockchain developer community that aims to decentralize, grow, and innovate the Polygon blockchain community. With over 68,000 members in its Official Community on Telegram , Polygon is a global leading blockchain with significant deployments.
Open Therapeutics is an open science company that freely provides the Therapoid platform that serves the interdisciplinary science, technology, engineering, math (STEM), arts (STEAM), Humanities, Social Sciences, and Economy (SHAPE) research and student communities. With its use of the Polygon blockchain, Therapoid provides members with ScienceCoins cryptocurrency and non-fungible token (NFT) awards.
According to the Polygon DAO's @ThePeacemaker82 , in the Polygon Official Community at Telegram and per the announcement in the joint PolygonDAO and Open Therapeutics Telegram channel:
thepeacemaker, [Oct 27, 2022 at 5:26:15 AM]:
Hi Therapoid @Jason_E_Barkeloo ! On behalf of the Polygon DAO, we'd like to congratulate your efforts with a [confidential] $USDC grant. Congrats and thank you for building on the Polygon network. We're excited to work together as we see your team grow!
Furthermore, we'd like to reward your team with our Marketing voucher. That's a great tool for our projects in which we will connect your team to a partnered marketing agency. This voucher is worth [confidential] and will be valid for one month. Here, I'll loop in ours heads of Vouchers, CB and Priya. @ckorlahalli_nft @priya1garg
As a part of your successful application, we'd also like to reward your team with our Starter Pack voucher to help consult and further develop your project. We've got an excellent group of dedicated personnel that will work with you in augmenting your current needs.
Our starter pack is a great initiative for projects that may benefit from consulting with a variety of our voucher partners.
Polygon is a decentralized Ethereum blockchain scaling platform that enables developers to build scalable user-friendly decentralized applications (dApps) with low transaction fees without ever sacrificing on security. Over 37,000 dApps have used Polygon to scale their performance and is a Web3 environment for all.
Polygon has a native cryptocurrency known as “MATIC”. MATIC is generally the 11th largest cap cryptocurrency with nearly an $8 billion USD market cap and doing well over $500 million USD in transactions per 24 hour period.
Open Therapeutics' mission is to provide the global research community a safe place to enable its members to positively impact human, animal, plant, and environmental health. Therapoid primarily provides advanced discussion forums. However, its members also have access to grants, intellectual properties, manuscript tools, free lab equipment, and ScienceCoins cryptocurrency and non-fungible token (NFT) awards.
According to Open Therapeutics Founder Jason E. Barkeloo, "We are very proud to gain this grant from the Polygon DAO! As we continue to use the Polygon blockchain, support from the Polygon DAO community will speed forward our developments. The implementation of our smart contracts on Polygon ensures low gas fees with high throughput for ScienceCoins and NFT transactions. In short, our Polygon implementation will benefit the global scientific community.”
About Polygon DAO
Led by a passionate group of developers, the Polygon DAO is a significant presence in the global blockchain ecosystem. On the Polygon blockchain, there are over 19,000 dApps, 130 million users, 3 million daily transactions, and nearly 3.5 billion transactions since inception. Polygon, formerly known as the Matic Network, is a blockchain scaling solution that provides tools to improve the speed and reduce the cost and complexities of transactions on blockchain networks. MATIC is used as the unit of payment and settlement between participants who interact within the network. At the center of Polygon is Ethereum, a platform where one can join virtual worlds (“metaverse”), play games, buy art, and conduct cryptocurrency and financial transactions. However, this much activity on Ethereum has made it almost unusable. To solve this problem, Polygon uses a layer-2 approach. As an add-on layer to Ethereum, the Polygon blockchain implementation is frequently referred to as "Ethereum's Internet of Blockchains".
About Open Therapeutics
The Company freely provides the scientific community the Therapoid open science and open access publishing platform. Therapoid is designed for interdisciplinary applied and fundamental researchers and students from the Science, Technology, Engineering, Math (STEM), Arts (STEAM), Humanities, Social Sciences, and Economy (SHAPE) philosophies. As a first of its kind Web3.0 and decentralized science (DeSci) ecosystem, Therapoid puts scientists and students at the center of positively impacting human, animal, plant, and global environmental health outcomes. As such, Therapoid is poised to be the world's largest think-tank. When its members freely opt-in, they can gain access to a larger ecosystem that provides intellectual properties (IP), grant fundings, free equipment, manuscript review tool (soon-to-be a preprint server), knowledge content center, and career opportunities. As its members interact and create content, they gain Ethereum and layer two Polygon blockchain-based ScienceCoins cryptocurrency and non-fungible token (NFT) awards. While its members use Therapoid.net they can also be seen by potential co-authors, grant funders, investors, recruiters for postdoctoral, gig, consulting, and employment opportunities. Therapoid members may also be visible to committees that award prizes such as Nobel, Fields, Turing, A.SK, Pulitzer, Kalinga, and L'Oréal-UNESCO. To help reduce misinformation, the public is also welcome. Free usage of Therapoid is provided via a Creative Commons 4.0 ShareAlike (CC4.0 ShareAlike) license.
Jason E. Barkeloo, Founder/Chair